Keynote: Fireside The Promise of Cell Therapy in Perilous Times for Policy

Session details:

Nkarta CEO Paul Hastings is an outspoken five-time biotech CEO and former chair of BIO, the world's largest biotechnology advocacy organization. He is also a patient advocate and an autoimmune patient leading a clinical-stage company pioneering natural killer (NK) cell therapy to treat autoimmune disease. In this fireside chat, he will talk about the therapeutic promise of NK cell therapy to achieve an "immune reset" and his company's efforts to advance this next-generation modality in what Hastings calls the most challenging policy environment for biotech companies and investors in American history.